Malicious PyPI packages give hackers control of Telegram bot servers

A campaign active since last November has been targeting Python developers building Telegram bots with trojanized Pyrogram ...
InfoQ

Million PDFs: Building a Modern Document Infrastructure with Rust and Typst

Erik Steiger discusses the operational pain of legacy PDF generation in regulated banking and manufacturing. He explains how ...
ZDNet

How to create a password-protected PDF with LibreOffice

Roku TV vs Fire Stick Galaxy Buds 3 Pro vs Apple AirPods Pro 3 M5 MacBook Pro vs M4 MacBook Air Linux Mint vs Zorin OS 4 quick steps to make your Android phone run like new again How much RAM does ...
9to5google

Gemini app can now generate Google Docs, PDF, Word, and other files

You can now ask the Gemini app to directly generate “downloadable and ready-to-share files.” Google wants you to “quickly move from a brainstorm to a complete ...
InfoWorld

Why it’s so hard to create stand-alone Python apps

If Python developers have one consistent gripe about their beloved language, it tends to be this: Why is it so hard to take a Python program and deploy it as a standalone artifact, the way C, C++, ...
Android

Google Gemini Can Now Generate & Download Files Directly in Your Chat

Google has updated Gemini to generate and package downloadable files like PDFs, Word, and Excel directly in the chat. This new feature, available globally, aims to eliminate the need for manual ...
GitHub

docuforge-launch-content-playbook.md

Everything you need to seed the internet with DocuForge content. Copy-paste ready. Name: "DocuForge Engineering" or "DocuForge Blog" or just your name (Fred Twum-Acheampong) Subdomain: ...
Reuters

Generate Biomedicines shares fall in weak Nasdaq debut for drug developer

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
MedCity News

Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Reuters

Drug developer Generate Biomedicines raises $400 million in US IPO

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...